curacle co.,ltd. (365270.KQ) — Stock Score Summary

curacle co.,ltd. (365270.KQ) has a MoatMap StockRank of 13/100 based on Quality (22/100), Value (34/100), and Momentum (41/100) factor scores. The current signal is STRONG SELL.

curacle co.,ltd., a bio-venture business, engages in the research and development of drugs for intractable vascular and metabolic diseases due to aging.

Key Financial Metrics

Price$7.70
Market Cap$165M
Price/Book6.62
Return on Equity-50.2%
Return on Invested Capital-40.8%
Debt/Equity28.60
Gross Margin98.7%
Operating Margin-285.9%
Free Cash Flow$-7K

curacle co.,ltd. operates in the Biotechnology industry, part of the Healthcare sector (South Korea).

Frequently Asked Questions

What is curacle co.,ltd.’s (365270.KQ) StockRank?
MoatMap’s StockRank for curacle co.,ltd. (365270.KQ) is 13/100, with a Strong Sell signal. It is a composite of Quality (22), Value (34), and Momentum (41) factor ranks across MoatMap’s 19,000+ stock universe.
Does curacle co.,ltd. have an economic moat?
curacle co.,ltd. (365270.KQ) has a Quality factor score of 22/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is curacle co.,ltd. a buy, hold, or sell?
MoatMap’s current signal for curacle co.,ltd. (365270.KQ) is Strong Sell, based on a StockRank of 13/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is curacle co.,ltd. in?
curacle co.,ltd. (365270.KQ) operates in the Healthcare sector, specifically the Biotechnology industry (South Korea).
Browse all ranked stocks365270.KQ deep dive reportAI ChampionsHow we score stocksSense-check another stock